TABLE 2

Levels of paclitaxel and docetaxel in the soluble fraction of human myocardial strips exposed to doxorubicin and taxanes-vehicles formulations Human myocardial strips were incubated in plasma and exposed to 10 μM doxorubicin and 2 to 15 μM paclitaxel or docetaxel formulated in their cosolvent systems (10 μl of ethanol/ml + 10 μl of Cremophor EL/ml, or 1 μl of ethanol/ml + 1 μl of polysorbate 80/ml, respectively). After 4 h, the soluble fraction of the strips was assayed for paclitaxel or docetaxel as described under Materials and Methods. All of the values were means ± S.E. of three to six experiments and were analyzed by one-way analysis of variance/Bonferroni's test for multiple comparisons; where indicated, unpaired Student's t test was also applied.


Taxane in Plasma

Taxane in the Soluble Fraction
Paclitaxel
Docetaxel
μM μM μM
2 0.9 ± 0.2 0.23 ± 0.1
6 2.5 ± 0.5a 1.5 ± 0.3c
15
6.4 ± 0.9b
6.4 ± 1.2d
  • a p > 0.05 versus 2 μM paclitaxel (p < 0.05 by unpaired Student's t test)

  • b p < 0.01 versus 2 or 6 μM paclitaxel

  • c p > 0.05 versus 2 μM docetaxel (p < 0.01 by unpaired Student's t test)

  • d p < 0.01 versus 2 or 6 μM docetaxel